Although signals that activate group 3 ILCs (ILC3s) have been described, the factors that negatively regulate these cells are less well understood. 
In Brief
Although signals that activate group 3 ILCs (ILC3s) have been described, the factors that negatively regulate these cells are less well understood. Bando et al. demonstrate that the TNF superfamily member RANKL suppresses the abundance and effector functions of intestinal CCR6 + ILC3s and that RANKLmediated suppression occurs through ILC3-ILC3 interactions. 
SUMMARY
While signals that activate group 3 innate lymphoid cells (ILC3s) have been described, the factors that negatively regulate these cells are less well understood. Here we found that the tumor necrosis factor (TNF) superfamily member receptor activator of nuclear factor kB ligand (RANKL) suppressed ILC3 activity in the intestine. Deletion of RANKL in ILC3s and T cells increased C-C motif chemokine receptor 6 (CCR6) + ILC3 abundance and enhanced production of interleukin-17A (IL-17A) and IL-22 in response to IL-23 and during infection with the enteric murine pathogen Citrobacter rodentium. Additionally, CCR6 + ILC3s produced higher amounts of the master transcriptional regulator RORgt at steady state in the absence of RANKL. RANKL-mediated suppression was independent of T cells, and instead occurred via interactions between CCR6 + ILC3s that expressed both RANKL and its receptor, RANK. Thus, RANK-RANKL interactions between ILC3s regulate ILC3 abundance and activation, suggesting that cell clustering may control ILC3 activity.
INTRODUCTION
Group 3 innate lymphoid cells (ILC3s) are innate lymphocytes that share developmental requirements for the transcription factor RORgt and that secrete the cytokines IL-22 and/or IL-17A (Artis and Spits, 2015; Bando and Colonna, 2016; Diefenbach et al., 2014; Eberl et al., 2015) . In mice, ILC3s are divided into subsets defined by differential expression of the surface markers CCR6 and NKp46. CCR6 + ILC3s are required for lymph node, Peyer's patch, and gut tertiary lymphoid tissue organogenesis; NKp46 + ILC3s express the transcription factor T-bet and can secrete interferon-g (IFN-g); and CCR6 À NKp46 À ILC3s have the capacity to differentiate into NKp46 + ILC3s (Klose et al., 2013; Sawa et al., 2010; van de Pavert and Vivier, 2016) . While NKp46 À ILC3s secrete both IL-22 and IL-17A, NKp46 + ILC3s
secrete IL-22 but not IL-17A. These cells are important sources of effector cytokines under steady state conditions, during recovery after radiation-induced tissue damage, and during infection with pathogens, including C. rodentium (Satoh-Takayama et al., 2008; Zheng et al., 2008) . In models of inflammatory bowel disease, ILC3 activation and cytokine secretion can alter intestinal pathology (Buonocore et al., 2010; Cox et al., 2012; Pearson et al., 2016; Song et al., 2015) . Unlike T cells, ILCs are activated by antigen-independent pathways. Group 3 ILCs are stimulated by soluble mediators, including the cytokines IL-23 and IL-1b. Bacterial metabolites and dietary components that engage the aryl hydrocarbon receptor (AHR) promote ILC3 proliferation and cytokine secretion (Kiss et al., 2011; Lee et al., 2011; Qiu et al., 2012) . Retinoic acid also enhances the production of IL-22 by ILC3s (Mielke et al., 2013) and regulates the size of the fetal and adult ILC3 pool (Spencer et al., 2014; van de Pavert et al., 2014) . More recently, glial cell-derived neurotrophic factor family of ligands (GFL) members (Ibiza et al., 2016) and prostaglandin E 2 (PGE 2 ) (Duffin et al., 2016) were shown to drive IL-22 production in ILC3s. The signals in tissue that negatively regulate ILC3 activity are less understood. IL-25, an alarmin secreted by intestinal Tuft cells (Gerbe et al., 2016; Howitt et al., 2016; von Moltke et al., 2016) , indirectly suppresses the production of IL-22 by ILC3s via myeloid cells (Sawa et al., 2011) . Butyrate has been reported to suppress Peyer's patch NKp46 + ILC3s (Kim et al., 2017) . Determining additional ways these cells are negatively regulated will provide insight into the balance of positive and negative signals that maintain intestinal homeostasis. Human and mouse ILC3s express the TNF superfamily member RANKL (Cella et al., 2010; Sugiyama et al., 2012) , a transmembrane and proteolytically shed homotrimer encoded by the gene Tnfsf11 (Walsh and Choi, 2014) . RANKL binds to the signaling receptor RANK and the soluble decoy receptor osteoprotegerin (OPG). Tnfsf11 À/À mice have defects in the development of osteoclasts, lactating mammary glands, medullary thymic epithelial cells (mTECs), and intestinal microfold (M) cells (Fata et al., 2000; Hikosaka et al., 2008; Knoop et al., 2009; Kong et al., 1999) . Additionally, Tnfsf11 À/À mice lack lymph nodes and have reduced tertiary gut lymphoid organs (Kim et al., 2000; Knoop et al., 2009; Kong et al., 1999 ). Peyer's patches still develop but are reduced in number in RANK-deficient mice (Dougall et al., 1999) . RANKL can promote dendritic cell (DC) survival during colitis in Il2 À/À mice (Ashcroft et al., 2003) , and is required for T cell localization in the central nervous system (CNS) during experimental autoimmune encephalomyelitis (EAE) (Guerrini et al., 2015) . RANKL is also required for regulatory T cell (Treg) generation in pancreatic lymph nodes and islets in a mouse model of diabetes (Green et al., 2002) , and exogenous administration of RANKL promotes oral tolerance to ovalbumin (Williamson et al., 2002) . To investigate the functions of RANKL in ILC3s, we generated conditionally deficient Tnfsf11 fl/fl Rorc Cre mice. In these mice, exons 3 and 4 of Tnfsf11 were excised in ILC3s and T cells as validated by genomic PCR ( Figure S1 ). RANKL deficiency in Tnfsf11 fl/fl Rorc Cre ILC3s was confirmed at the protein level by cell surface antibody staining ( Figure 1A (Gasteiger et al., 2015) , administration of blocking antibodies to adult mice would be expected to block RANK signaling among mature ILC3s in the tissue, rather than affect ILC3 development. Intestinal CCR6 + ILC3s isolated from mice treated with blocking antibody exhibited increased CCR6 expression ( Figure 2E ) and produced increased amounts of IL-17A and IL-22 upon stimulation with IL-23 compared to cells isolated from mice treated with isotype control antibody (Figure 2F) (Akiyama et al., 2008; Hikosaka et al., 2008; Rossi et al., 2007 Figure 3D ). In support of these data, administration of a RANKL blocking antibody to Rag1 À/À mice induced elevated CCR6 expression ( Figure 3E ) and increased IL-23-elicited cytokine production in vitro by CCR6 + ILC3s ( Figure 3F ). To test whether RANKL-deficient T cells were sufficient to induce ILC3 hyperresponsiveness, we used chimeric mice that lacked RANKL in T cells, while retaining RANKL-sufficient CCR6 Bars indicate mean (+/À SD). **p % 0.01, ***p % 0.001, ****p % 0.0001. Data are representative of three independent experiments (A and B), are pooled from two independent experiments (C), or are representative of two independent experiments (D). Also see Figure S1 .
ILC3s ( Figure 3G ). These mice were generated by transferring (D) CCR6 + ILC3 cell counts (left) and percent of CCR6 + ILC3s that produced IL-17A and IL-22 on d 7 of infection (center and right) (n = 7-11).
(E) CCR6 expression and (F) cytokine production in CCR6 + ILC3s after in vivo treatment with a blocking antibody to RANKL (n = 4). Bars indicate mean (+/À SD).
*p % 0.05, **p % 0.01, ***p % 0.001, ****p % 0.0001. Data are representative of two independent experiments (A, B, E, and F), or two independent experiments pooled (C and D). Figure 4A and data not shown).
Since the expression of RANK in each ILC3 subset correlated with the extent each population was functionally affected by RANKL deficiency, we hypothesized that ILC3s were suppressed by directly responding to RANKL. Importantly, CCR6 + ILC3s (1) not only expressed high amounts of RANK, but also expressed more RANKL than other ILC3 subsets ( Figure 4B ), and (2) reside in cryptopatches, anatomical sites where these cells are closely clustered together and thus have high potential for ILC3-ILC3 interactions (L€ ugering et al., 2010 (Lam et al., 2001; Nelson et al., 2012) , CCR6 + ILC3s produced less IL-17A and IL-22 in response to IL-23 and IL-1b in comparison to cells cultured in media alone ( Figure 4C ). In contrast, pretreatment of purified CCR6 + ILC3s with a RANKL blocking antibody led to increased IL-17A and IL-22 production after IL-23 and IL-1b stimulation, indicating that ILC3s can suppress each other in a RANKL-dependent manner in vitro ( Figure 4D ). The ILC3 cell line MNK-3, which expresses both RANK and RANKL (Allan et al., 2015) , also produced significantly less IL-17A and IL-22 after pretreatment with homotrimeric RANKL compared to control cells, while administration of a RANKL-blocking antibody to MNK-3 cultures elevated IL-17A and IL-22 production compared to isotype control-treated cells ( Figures S3A and  S3B (Figure 5D ). Thus, RANK is required for the suppression of CCR6 + ILC3 proliferation and effector cytokine production. Membrane-bound RANKL can be proteolytically cleaved and released by osteoblasts (Lum et al., 1999; Nakashima et al., 2000) . To determine whether ILC3s also shed RANKL, we assessed supernatants from sorted CCR6 + ILC3 cultures for soluble RANKL by ELISA. Over 3 days, RANKL was undetectable in supernatants but abundant in cell lysates, indicating that RANKL primarily remains bound to the cell surface under non-stimulatory conditions ( Figure S5A ). Upon stimulation with IL-23 and IL-1b, supernatants contained soluble RANKL, while the abundance of membrane-bound RANKL was reduced ( Figures S5B  and S5C ). These data suggest that at steady state, RANK-RANKL interactions between CCR6 + ILC3s occur primarily through direct cell-cell contact rather than through soluble RANKL. However, because RANKL might be shed upon stimulation, direct cell contact might not be required for RANK signaling upon cellular activation.
RANK and RANKL Conditionally Deficient Mice Have Partial Defects in Secondary Lymphoid Tissue Organogenesis
Unlike Tnfsf11 À/À and Tnfrsf11a À/À mice, which have impaired lymph node organogenesis (Dougall et al., 1999; Kim et al., 2000; Kong et al., 1999) Figure 6A ). To test the possibility that intact lymph node development in these mice was due to inefficient Cre-mediated deletion during lymph node organogenesis, we generated additional mice expected to have higher RANK or RANKL deletion efficiency by introducing alleles with germline deletion of Tnfsf11 or Tnfrsf11a to individual animals. Conditional RANK mice carrying one germline deleted allele of Tnfrsf11a (Tnfrsf11a Peyer's patches were typically absent from the proximal region of Tnfsf11 fl/fl Rorc Cre small intestines ( Figure S6A ). In comparison, Rag1 À/À mice exhibited normal Peyer's patch distribution, demonstrating that T cells are not required for the development of proximal Peyer's patches ( Figure S6A ). Gut tertiary lymphoid organs were not reduced in Tnfsf11 fl/fl Rorc Cre mice ( Figure S6B ).
Although M cell development is reduced in Tnfsf11 À/À mice (Knoop et al., 2009 ), normal M cell populations were found within follicle-associated epithelium (FAE) in Peyer's patches from Tnfsf11 fl/fl Rorc Cre mice ( Figure S6C ), consistent with recent findings that RANKL is not required in hematopoietic cells for M cell development (Nagashima et al., 2017 Figure 7A, B) . Cd69, which is induced upon lymphocyte activation, was also more highly expressed in RANKL-deficient cells. In contrast, genes induced by RANK signaling in osteoclasts, including Bmp2 and Nfkb2 (Cappellen et al., 2002; Wittrant et al., 2006) , as well as Runx2, a regulator of Bmp2-induced signaling in osteoclasts (Rahman et al., 2015) , were more highly expressed in RANKL-sufficient CCR6 + ILC3s.
CCR6 + ILC3s from Tnfsf11 fl/fl Rorc
Cre and Tnfsf11 fl/fl mice also differed in their transcription of cytokines and receptors to soluble molecules. RANKL-deficient ILC3s more highly expressed Tnf and Lif, as well as the semaphorin Sema4b. RANKL-deficient ILC3s also exhibited increased expression of the leukotriene receptors Cysltr2 and Ltb4r1, while control cells had increased expression of Vipr2, which encodes a receptor that binds the peptide hormone vasoactive intestinal peptide (VIP). These data suggest that RANK signaling alters the production of additional cytokines beyond IL-22 and IL-17A and might induce differential responsiveness to leukotrienes and VIP.
To test whether differences in Rorc transcript expression led to changes in RORgt abundance, we assessed RORgt protein levels in CCR6 + ILC3s ex vivo. By intracellular antibody staining, more RORgt was detected in CCR6 + ILC3s from Tnfsf11 fl/fl Rorc Cre mice compared to Tnfsf11 fl/fl cells ( Figure 7C ), as well as in CCR6 + ILC3s from RANKL antibody-treated mice compared to isotype control-treated mice ( Figure 7D ). Together, our data indicate that RANK-RANKL signaling under homeostasis induces an altered state in CCR6 + ILC3s defined by reductions in both RORgt expression and canonical ILC3 effector function.
DISCUSSION
Here, we demonstrated that RANKL suppressed CCR6 + ILC3
proliferation and activity in the small intestine. Mice conditionally deficient in RANKL in ILC3s and T cells had increased numbers (Dougall et al., 1999; Kim et al., 2000; Kong et al., 1999; Mueller and Hess, 2012 (Nagashima et al., 2017) . We conclude that other cell types besides ILC3s provide RANKL during lymph node organogenesis and M cell induction. In summary, our study demonstrates that RANKL controls CCR6 + ILC3 proliferation and effector cytokine production through ILC3-ILC3 interactions that activate RANK signaling and suppress expression of RORgt. These observations may open new avenues of therapeutic intervention in intestinal infections and inflammatory bowel diseases through the modulation of ILC3 activation.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODELS AND SUBJECT DETAILS Animals
Six-to 12-week-old male and female mice were used in this study. Sex-and age-matched littermates were used within each experiment, and were randomly assigned to experimental groups. All mice were backcrossed to the C57BL/6 background.
Rag1
À/À and Tnfrsf11a fl/fl mice were purchased from Jackson Laboratories. Rorc Cre/+ mice (Eberl and Littman, 2004) were provided by Gerard Eberl. Tnfrsf11a eGFP-Cre mice (Maeda et al., 2012) were provided by Deborah Novack and Yasuhiro Kobayashi. Tnfsf11 fl/fl (Tnfsf11 tm1c/tm1c ) mice were generated from ES cells purchased from Eucomm (Tnfsf11 EPD0724_4_C08; Tnfsf11 tm1a (EUCOMM)Wtsi ) and B6.Tg(CAG-FLP3e)36 mice from RIKEN (Kanki et al., 2006) as previously described (Bando et al., 2015) . All Rorc Cre Tnfsf11 fl/fl and Rorc Cre Tnfrsf11a fl/fl mice reported in this study were genotyped against germline deletion of Tnfsf11 or Tnfrsf11a. Mice were maintained in specific pathogen-free facilities at Washington University in Saint Louis. All studies were conducted in accordance with the Washington University Animal Studies Committee.
Human Studies
Pediatric tonsils were obtained from tonsillectomies performed at Children's Hospital in Saint Louis under the approval of institutional review boards of Washington University in Saint Louis and with informed consent. The samples were provided as surgical waste with no identifiers attached. Tonsils were minced, disupted against mesh, and enriched for CD56 + cells using microbeads (Miltenyl biotec 
Cell Lines and Primary Cell Cultures
Cells were cultured at 37 C under 5% CO 2 . MNK-3 cells and primary mouse cells were cultured in RPMI 1640 supplemented with sodium pyruvate, HEPES, kanamycin sulfate, glutamine, nonessential amino acids, b-mercaptoethanol, and 10% BCS. Human primary cells were cultured in RPMI 1640 supplemented with sodium pyruvate, kanamycin sulfate, ciprofloxacin (Bayer), glutamine, nonessential amino acids, b-mercaptoethanol, and 10% FCS (Atlanta Biologics). For 3 d cultures, media was supplemented with 4% in-house generated mouse IL-7 supernatant for mouse cells or 50 ng/ml recombinant human IL-7 for human cells. The sex of MNK-3 cells has not been determined.
Method Details
Tissue Dissociation Small intestines were flushed to remove luminal contents and Peyer's patches were removed. Intestines were opened lengthwise and gently agitated for 20 min in HBSS containing HEPES, BCS, and EDTA. Intestines were votexed before subjected to a second round of gentle agitation and vortexing in EDTA. The tissue was then rinsed with HBSS prior to digestion with Collagenase IV (Sigma) in complete RPMI-10 for 40 min at 37 C under agitation. Digests were filtered through 100 micron mesh and subjected to density gradient centrifugation using 40% and 70% Percoll solutions. To isolate thymic epithelial cells, thymii were mechanically dissociated in RPMI containing 2% BCS. The tissue was then digested with Liberase and Dnase I for 40 min at 37 C, and then treated with EDTA for 5 min. Digested samples were vortexed, filtered, and subjected to density gradient centrifugation using media and a 50% Percoll solution. To generate single cell suspensions of peripheral lymph nodes, inguinal, axillary, brachial, and cervical lymph nodes were pooled and mashed against a 70 micron mesh filter. 
